SARMs
Ligandrol (LGD-4033)
LGD-4033 · LGD · Anabolicum
Potent SARM for lean mass; suppression evident at higher doses.
🚧 Expanded guide coming soon. This compound has PK data and a source — a full overview, mechanism, and dosing guide is pending editorial review.
Pharmacokinetic summary
- Model tier
- Advanced (t½ + Cmax + Tmax + F)
- Half-life
- 1 days
- Cmax
- 498 ng/mL
- Tmax
- 0.1 days
- Bioavailability
- 60%
- Typical dose
- 2–10 mg
Harm reduction
- Aromatizes
- No
- Hepatotoxicity
- mild
- Injection frequency
- Oral, daily
Related compounds
Ostarine (MK-2866 / Enobosarm)
Non-steroidal SARM; mild, used in cutting/recomp. Simple model (estimated).
Andarine (S4)
SARM with notable vision-related side effects; short half-life requiring divided dosing.
Testolone (RAD-140)
Potent SARM; suppression and hepatotoxicity reported at higher doses.
Protocols featuring Ligandrol (LGD-4033)
Comments
Loading comments…